Most of these devices are made around specific drug brands by the drug companies them self. Take Spiriva Respimat as an example, it's device can only be used for it's drug's & not others.
ADR can be used on most drugs, it's key for growth is making it's devices stand out from the rest.. So far from what i read it looks like it is a stand out from a functionally point of view with phone app & stuff..
An issue though is that when you go see a doctor for an inhaler, he will recommend the big brands as the have paid him to do so..
The market is worth billions & not slowing down.. How does ADR compete with that even if there product is a stand out ?
I haven't gone over the quarterly's but what i would do is watch for growth.. If it's clear that growth is made quarter by quarter then it's worth the punt.. especially when it has been beaten down by the looks of the chart.
